These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35440571)

  • 1. Toward therapeutic electrophysiology: beta-band suppression as a biomarker in chronic local field potential recordings.
    Feldmann LK; Lofredi R; Neumann WJ; Al-Fatly B; Roediger J; Bahners BH; Nikolov P; Denison T; Saryyeva A; Krauss JK; Faust K; Florin E; Schnitzler A; Schneider GH; Kühn AA
    NPJ Parkinsons Dis; 2022 Apr; 8(1):44. PubMed ID: 35440571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic beta band suppression reflects effective neuromodulation in chronic recordings.
    Feldmann LK; Neumann WJ; Krause P; Lofredi R; Schneider GH; Kühn AA
    Eur J Neurol; 2021 Jul; 28(7):2372-2377. PubMed ID: 33675144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of beta bursts in subthalamic sensorimotor circuits predicts improvement in bradykinesia.
    Kehnemouyi YM; Wilkins KB; Anidi CM; Anderson RW; Afzal MF; Bronte-Stewart HM
    Brain; 2021 Mar; 144(2):473-486. PubMed ID: 33301569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic beta dynamics mirror Parkinsonian bradykinesia months after neurostimulator implantation.
    Steiner LA; Neumann WJ; Staub-Bartelt F; Herz DM; Tan H; Pogosyan A; Kuhn AA; Brown P
    Mov Disord; 2017 Aug; 32(8):1183-1190. PubMed ID: 28639263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Sensing of Subthalamic Local Field Potentials: Comparison of First and Second Generation Implantable Bidirectional Systems Within a Single Subject.
    Cummins DD; Kochanski RB; Gilron R; Swann NC; Little S; Hammer LH; Starr PA
    Front Neurosci; 2021; 15():725797. PubMed ID: 34447294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta bursts during continuous movements accompany the velocity decrement in Parkinson's disease patients.
    Lofredi R; Tan H; Neumann WJ; Yeh CH; Schneider GH; Kühn AA; Brown P
    Neurobiol Dis; 2019 Jul; 127():462-471. PubMed ID: 30898668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and Rebound of Pallidal Beta Power: Observation Using a Chronic Sensing DBS Device.
    Cagle JN; Wong JK; Johnson KA; Foote KD; Okun MS; de Hemptinne C
    Front Hum Neurosci; 2021; 15():749567. PubMed ID: 34566612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity.
    Sinclair NC; McDermott HJ; Fallon JB; Perera T; Brown P; Bulluss KJ; Thevathasan W
    Neurobiol Dis; 2019 Oct; 130():104522. PubMed ID: 31276793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease.
    Averna A; Marceglia S; Arlotti M; Locatelli M; Rampini P; Priori A; Bocci T
    Clin Neurophysiol; 2022 Jan; 133():29-38. PubMed ID: 34794045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pallidal deep brain stimulation modulates excessive cortical high β phase amplitude coupling in Parkinson disease.
    Malekmohammadi M; AuYong N; Ricks-Oddie J; Bordelon Y; Pouratian N
    Brain Stimul; 2018; 11(3):607-617. PubMed ID: 29422442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bocci T; Prenassi M; Arlotti M; Cogiamanian FM; Borellini L; Moro E; Lozano AM; Volkmann J; Barbieri S; Priori A; Marceglia S
    NPJ Parkinsons Dis; 2021 Sep; 7(1):88. PubMed ID: 34584095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent suppression of subthalamic beta-band activity during rhythmic finger tapping in Parkinson's disease.
    Joundi RA; Brittain JS; Green AL; Aziz TZ; Brown P; Jenkinson N
    Clin Neurophysiol; 2013 Mar; 124(3):565-73. PubMed ID: 23085388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term correlation of subthalamic beta band activity with motor impairment in patients with Parkinson's disease.
    Neumann WJ; Staub-Bartelt F; Horn A; Schanda J; Schneider GH; Brown P; Kühn AA
    Clin Neurophysiol; 2017 Nov; 128(11):2286-2291. PubMed ID: 29031219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease.
    van Wijk BC; Beudel M; Jha A; Oswal A; Foltynie T; Hariz MI; Limousin P; Zrinzo L; Aziz TZ; Green AL; Brown P; Litvak V
    Clin Neurophysiol; 2016 Apr; 127(4):2010-9. PubMed ID: 26971483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight cylindrical contact lead recordings in the subthalamic region localize beta oscillations source to the dorsal STN.
    Tamir I; Wang D; Chen W; Ostrem JL; Starr PA; de Hemptinne C
    Neurobiol Dis; 2020 Dec; 146():105090. PubMed ID: 32977021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of Cortico-Subthalamic Projections Amplifies Resting Motor Circuit Activity and Leads to Increased Locomotion in Dopamine-Depleted Mice.
    Sanders TH
    Front Integr Neurosci; 2017; 11():24. PubMed ID: 29033800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation.
    Quinn EJ; Blumenfeld Z; Velisar A; Koop MM; Shreve LA; Trager MH; Hill BC; Kilbane C; Henderson JM; Brontë-Stewart H
    Mov Disord; 2015 Nov; 30(13):1750-8. PubMed ID: 26360123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive deep brain stimulation as advanced Parkinson's disease treatment (ADAPT study): protocol for a pseudo-randomised clinical study.
    Piña-Fuentes D; Beudel M; Little S; Brown P; Oterdoom DLM; van Dijk JMC
    BMJ Open; 2019 Jun; 9(6):e029652. PubMed ID: 31201193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.